Treatment Registry
TR-1195 ActiveRecorded November 2026

Brand tirzepatide

Sold by Luvo Health · Injection · device not recorded · every brand tirzepatide record

The program identifies an injection, but the delivery device has not been established.

Price

TermPublished ratePublished payment
Recurring four-week order

Published four-week product price; a prescription and individualized plan are required. The pricing page states billing every 28 days. This is not a calendar-month price or a guaranteed individual invoice.

“Included in your price Your medication Clinician review Ongoing support and check-ins Discreet shipping to your door No membership fees $1399 4 weeks of injections, delivered every 4 weeks.”

$1,399Per 4 weeksPublished payment$1,399
Price sources
Enroll with Luvo Health

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • November 2026 — Entry added to the register

Sourcing and terms

Pharmacyindividual dispensing pharmacy not disclosed. The terms identify a possible pharmacy network, not the dispenser assigned to this prescription.
Statesmedication-specific eligibility not disclosed. General nationwide service language is qualified by service and state availability; no medication-specific roster is established.
Prescriberrequired visit format not disclosed. Online intake, messaging, audio and video are described; the required format depends on clinician judgment and state rules.
CancellationThe refund policy requires 72 hours before the next billing date; the terms require 72 hours before renewal or renewal processing, which may occur up to two days early. Confirm the processing date and medication-order cutoff. Refunds also depend on clinical services already rendered and bundle deductions.
MembershipNone. “No membership fees”
Consult feeIncluded in program price; itemized amount is not published. Clinician review is included in the advertised product price; no separate component amount is given.

Recorded from luvohealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. November 2026 — Product prices include medication, clinician review, ongoing support and check-ins, and shipping. The pricing page says there is no membership fee. The general FAQ also allows a professional review fee if shown before payment; confirm any separate charge before enrolling.
  2. 2. November 2026 — The pricing page describes a first 28-day cycle followed by standard-price billing every 28 days. Four weeks is not a calendar month. Longer plan lengths are mentioned, but the current pages do not establish the older 12-, 24- or 52-week payment totals.
  3. 3. November 2026 — The refund policy says the first payment is charged when intake is completed. Product pages say there is no commitment until clinician review, and the microdosing FAQ says payment follows review and a prescription. Confirm the charge timing and what happens if treatment is declined.
  4. 4. November 2026 — The refund policy requires cancellation at least 72 hours before the next billing date. The terms instead refer to renewal or the renewal-processing date and allow charges and shipments to process up to two days early, including around weekends or holidays. Check the actual processing date; a late request can leave the next cycle charged.
  5. 5. November 2026 — The refund policy offers a full refund for medical disqualification before medication is ordered, but also says rendered clinical services are nonrefundable. It defines an order as a prescription issued and transmitted to the pharmacy; new-patient intake, a required video visit, or a refill intake may trigger that point. Confirm how those provisions apply before submitting an intake.
  6. 6. November 2026 — Refunds are generally limited to the current cycle before medication is ordered; prior cycles are excluded. Bundle refunds deduct shipments received at the standard non-bundled monthly retail price in effect at purchase. Damaged or incorrect orders are reviewed for replacement or a case-specific refund.
  7. 7. November 2026 — The terms name Red Rock Compounding Pharmacy, HealthWarehouse, Precision Medicine and Triad Rx as possible network pharmacies. They do not assign a dispenser to this prescription. The FAQ permits outside pharmacy transfers, warns that compounded transfers may be impractical, and says outside pricing and a possible coordination fee can differ.
  8. 8. November 2026 — Clinical review can include online information and, when required, a phone or video visit. The general terms describe services in all 50 states and Washington, DC, while warning that individual services are not available everywhere. Medication-specific eligibility remains unconfirmed.
  9. 9. November 2026 — The weight-loss FAQ says labs may be needed. The microdosing FAQ says Luvo does not run tests and patients arrange recommended bloodwork through their own provider. A GLP-1 lab charge or inclusion is not established by the testosterone-only lab exception on the pricing page.
  10. 10. November 2026 — The pricing page and terms describe cash-pay care, while general and brand FAQs discuss possible insurance workflows. That does not confirm insurance acceptance for this program. Luvo describes itself as a nonclinical platform; its privacy policy distinguishes platform information from clinical partners’ HIPAA-governed records and permits additional service-provider disclosures.
  11. 11. November 2026 — The product description establishes an injection. The device for an individual prescription remains unconfirmed; illustrative product images are not dispensing proof.

7 further notes concern other Luvo Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1195
Medication category
brand tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Luvo Health — brand tirzepatide (TR-1195). Last verified November 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1195

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.